1	Evidence	evidence	_	_	_	_	_	_	_
2	that	that	_	_	_	_	_	_	_
3	calcineurin	calcineurin	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	rate-limiting	rate-limiting	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	primary	primary	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	lymphocyte	lymphocyte	_	_	_	_	_	_	_
10	activation	activation	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	Cyclosporine	cyclosporine	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	CsA	CsA	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	both	both	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	clinical	clinical	_	_	_	_	_	_	_
9	immunosuppressive	immunosuppressive	_	_	_	_	_	_	_
10	drug	drug	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	probe	probe	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	dissect	dissect	_	_	_	_	_	_	_
16	intracellular	intracellular	_	_	_	_	_	_	_
17	signaling	signaling	_	_	_	_	_	_	_
18	pathways	pathway	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	vitro	vitro	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	CsA	CsA	_	_	_	_	_	_	_
5	inhibits	inhibit	_	_	_	_	_	_	_
6	lymphocyte	lymphocyte	_	_	_	_	_	_	_
7	gene	gene	_	_	_	_	_	_	_
8	activation	activation	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	inhibiting	inhibit	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	phosphatase	phosphatase	_	_	_	_	_	_	_
13	activity	activity	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	calcineurin	calcineurin	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	CN	CN	_	_	_	_	_	_	_
18	)	)	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	clinical	clinical	_	_	_	_	_	_	_
3	use	use	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	CsA	CsA	_	_	_	_	_	_	_
6	treatment	treatment	_	_	_	_	_	_	_
7	inhibits	inhibit	_	_	_	_	_	_	_
8	50-75	50-75	_	_	_	_	_	_	_
9	%	%	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	CN	cn	_	_	_	_	_	_	_
12	activity	activity	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	circulating	circulate	_	_	_	_	_	_	_
15	leukocytes	leukocyte	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	modeled	model	_	_	_	_	_	_	_
3	this	this	_	_	_	_	_	_	_
4	degree	degree	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	CN	cn	_	_	_	_	_	_	_
7	inhibition	inhibition	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	primary	primary	_	_	_	_	_	_	_
10	human	human	_	_	_	_	_	_	_
11	leukocytes	leukocyte	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	vitro	vitro	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	order	order	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	study	study	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	effect	effect	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	partial	partial	_	_	_	_	_	_	_
22	CN	cn	_	_	_	_	_	_	_
23	inhibition	inhibition	_	_	_	_	_	_	_
24	on	on	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	downstream	downstream	_	_	_	_	_	_	_
27	signaling	signaling	_	_	_	_	_	_	_
28	events	event	_	_	_	_	_	_	_
29	that	that	_	_	_	_	_	_	_
30	lead	lead	_	_	_	_	_	_	_
31	to	to	_	_	_	_	_	_	_
32	gene	gene	_	_	_	_	_	_	_
33	activation	activation	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	CsA-treated	csa-treated	_	_	_	_	_	_	_
3	leukocytes	leukocyte	_	_	_	_	_	_	_
4	stimulated	stimulate	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	calcium	calcium	_	_	_	_	_	_	_
7	ionophore	ionophore	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	degree	degree	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	reduction	reduction	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	CN	cn	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	was	be	_	_	_	_	_	_	_
17	accompanied	accompany	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	a	a	_	_	_	_	_	_	_
20	similar	similar	_	_	_	_	_	_	_
21	degree	degree	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	inhibition	inhibition	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	each	each	_	_	_	_	_	_	_
26	event	event	_	_	_	_	_	_	_
27	tested	test	_	_	_	_	_	_	_
28	:	:	_	_	_	_	_	_	_
29	dephosphorylation	dephosphorylation	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	nuclear	nuclear	_	_	_	_	_	_	_
32	factor	factor	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	activated	activate	_	_	_	_	_	_	_
35	T	t	_	_	_	_	_	_	_
36	cell	cell	_	_	_	_	_	_	_
37	proteins	protein	_	_	_	_	_	_	_
38	,	,	_	_	_	_	_	_	_
39	nuclear	nuclear	_	_	_	_	_	_	_
40	DNA	dna	_	_	_	_	_	_	_
41	binding	binding	_	_	_	_	_	_	_
42	,	,	_	_	_	_	_	_	_
43	activation	activation	_	_	_	_	_	_	_
44	of	of	_	_	_	_	_	_	_
45	a	a	_	_	_	_	_	_	_
46	transfected	transfecte	_	_	_	_	_	_	_
47	reporter	reporter	_	_	_	_	_	_	_
48	gene	gene	_	_	_	_	_	_	_
49	construct	construct	_	_	_	_	_	_	_
50	,	,	_	_	_	_	_	_	_
51	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
52	and	and	_	_	_	_	_	_	_
53	IL-2	il-2	_	_	_	_	_	_	_
54	mRNA	mrna	_	_	_	_	_	_	_
55	accumulation	accumulation	_	_	_	_	_	_	_
56	,	,	_	_	_	_	_	_	_
57	and	and	_	_	_	_	_	_	_
58	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
59	production	production	_	_	_	_	_	_	_
60	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	degree	degree	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	CN	cn	_	_	_	_	_	_	_
7	inhibition	inhibition	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	reflected	reflect	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	similar	similar	_	_	_	_	_	_	_
13	degree	degree	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	reduction	reduction	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	lymphocyte	lymphocyte	_	_	_	_	_	_	_
18	proliferation	proliferation	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	IFN-gamma	IFN-gamma	_	_	_	_	_	_	_
21	production	production	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	allogeneic	allogeneic	_	_	_	_	_	_	_
25	mixed	mixed	_	_	_	_	_	_	_
26	lymphocyte	lymphocyte	_	_	_	_	_	_	_
27	cultures	culture	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	support	support	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	conclusion	conclusion	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	CN	cn	_	_	_	_	_	_	_
8	activity	activity	_	_	_	_	_	_	_
9	is	be	_	_	_	_	_	_	_
10	rate-limiting	rate-limiting	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	primary	primary	_	_	_	_	_	_	_
16	human	human	_	_	_	_	_	_	_
17	T	t	_	_	_	_	_	_	_
18	lymphocytes	lymphocyte	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	reduction	reduction	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	CN	cn	_	_	_	_	_	_	_
7	activity	activity	_	_	_	_	_	_	_
8	observed	observe	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	CsA-treated	csa-treated	_	_	_	_	_	_	_
11	patients	patient	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	accompanied	accompany	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	a	a	_	_	_	_	_	_	_
16	similar	similar	_	_	_	_	_	_	_
17	degree	degree	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	reduction	reduction	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	lymphocyte	lymphocyte	_	_	_	_	_	_	_
22	gene	gene	_	_	_	_	_	_	_
23	activation	activation	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	accounts	account	_	_	_	_	_	_	_
27	for	for	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	immunosuppression	immunosuppression	_	_	_	_	_	_	_
30	observed	observe	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

